Se‐Hoon Lee

Also affiliated with Samsung (South Korea), Samsung Medical Center, Seoul Medical Center, Bristol-Myers Squibb (South Korea), Sungkyunkwan University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer”.

Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer

New England Journal of Medicine(2023)10.1056/nejmoa2302983

N/A

7.3DataRank · unranked

1056 citations

Moïshe Liberman, Terufumi Kato, Masahiro Tsuboi, Se‐Hoon Lee, Shugeng Gao +14 more

Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet(2024)10.1016/s0140-6736(24)01756-2

N/A

3.7DataRank · unranked

262 citations

Marina Chiara Garassino, Heather A. Wakelee, Moïshe Liberman, Terufumi Kato, Masahiro Tsuboi +91 more

Lung adenocarcinoma promotion by air pollutants

Nature(2023)10.1038/s41586-023-05874-3

N/A

0.998DataRank · unranked

775 citations

Emilia L. Lim, Clare E. Weeden, Claudia Lee, Marcellus Augustine, Kezhong Chen +95 more

High-Resolution Profiling of Lung Adenocarcinoma Identifies Expression Subtypes with Specific Biomarkers and Clinically Relevant Vulnerabilities

Cancer Research(2022)10.1158/0008-5472.can-22-0432

N/A

0DataRank · unranked

36 citations

Yifat Geffen, Hongui Cha, Mendy Miller, Shankara Anand, Jaegil Kim +8 more

Robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical, pathologic, and genomic features

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.04.547697

N/A

0DataRank · unranked

0 citations

Yingying Cao, Hannah J. Sfreddo, Saugato Rahman Dhruba, Se‐Hoon Lee, Cristina Valero +5 more

Data from High-Resolution Profiling of Lung Adenocarcinoma Identifies Expression Subtypes with Specific Biomarkers and Clinically Relevant Vulnerabilities

(2023)10.1158/0008-5472.c.6514175

N/A

0DataRank · unranked

0 citations

Yifat Geffen, Hongui Cha, Mendy Miller, Shankara Anand, Jaegil Kim +8 more

Robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical, pathologic, and genomic features

Research Square(2023)10.21203/rs.3.rs-3087126/v1

N/A

0DataRank · unranked

0 citations

Tiangen Chang, Yingying Cao, Hannah Sfreddo, Saugato Rahman Dhruba, Se‐Hoon Lee +5 more

LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features

Nature Cancer(2024)10.1038/s43018-024-00772-7

N/A

0DataRank · unranked

114 citations

Yingying Cao, Hannah J. Sfreddo, Saugato Rahman Dhruba, Se‐Hoon Lee, Cristina Valero +5 more

New Approaches to SCLC Therapy: From the Laboratory to the Clinic

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.01.016

N/A

0DataRank · unranked

177 citations

Julie George, Taofeek K. Owonikoko, Anton Berns, Élisabeth Brambilla, Lauren A. Byers +42 more

Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008339

N/A

0DataRank · unranked

53 citations

Yoon-La Choi, Taebum Lee, Hyojin Kim, Young Kwang Chae, Ben W. Dulken +25 more

Whole exome precision oncology targeting synthetic lethal vulnerabilities across the tumor transcriptome

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.02.16.951699

N/A

0DataRank · unranked

1 citations

Nishanth Ulhas Nair, Lesley M. Chapman, Sanju Sinha, Kun Wang, Houngui Cha +10 more

Synthetic lethality-mediated precision oncology via the tumor transcriptome

Cell(2021)10.1016/j.cell.2021.03.030

N/A

0DataRank · unranked

159 citations

Nishanth Ulhas Nair, Gal Dinstag, Lesley M. Chapman, Youngmin Chung, Kun Wang +18 more